Tag: NASDAQ:OCLS

  • Why Need to Watch: Microsoft Corporation (NASDAQ:MSFT), Imprimis Pharmaceuticals (NASDAQ:IMMY), Oculus Innovative Sciences (NASDAQ:OCLS), The New York Times (NYSE:NYT)

    IT major Microsoft Corporation (NASDAQ:MSFT) has partnered with HP and Pearson to launch a tablet for higher educational students in engineering and management streams. Microsoft Corporation (NASDAQ:MSFT) shares after opening at $39.96 moved to $40.14 on last trade day and at the end of the day closed at $39.99. Company price to sales ratio in past twelve months was calculated as 3.98 and price to cash ratio as 3.97. Microsoft Corporation (NASDAQ:MSFT) showed a positive weekly performance of 2.07%.

    Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a vertically-integrated specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, announced its attendance and physicians’ presentations at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium & Congress in Boston from April 25-29, 2014.  Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) shares advanced 6.01% in last trading session and ended the day on $7.23. IMMY return on equity ratio is recorded as -47.10% and its return on assets is -44.40%. Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) yearly performance is -19.67%.

    Two months after it was approved, a mouth and throat infection treatment developed by Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) went on sale in Mexico. Petaluma-based Oculus (NASDAQ: OCLS) is selling the product, Microdacyn60 Bucofaringeo, through a Latin American partner, More Pharma.Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) shares was closed at $3.24, while trading in range of $3.18-$3.32. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) year to date performance is -6.90%.

    The New York Times Company (NYSE:NYT) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued to investors on Thursday,AmericanBankingNews.com reports. They currently have a $17.00 target price on the stock. Zacks‘s price target suggests a potential upside of 8.70% from the company’s current price. The New York Times Company (NYSE:NYT) weekly performance is 9.25%. On last trading day company shares ended up $17.00. The New York Times Company (NYSE:NYT) distance from 50-day simple moving average is 6.66%. Analysts mean target price for the company is $15.50.